Clopidogrel Use and Long-term Safety After Drug-Eluting Stents Implantation

PHASE4CompletedINTERVENTIONAL
Enrollment

1,175

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

April 30, 2010

Conditions
Coronary Artery Disease
Interventions
DRUG

Aspirin

stopping clopidogrel at 1 year after DES implantation

DRUG

Aspirin,Clopidogrel

continue aspirin and clopidogrel 1year after DES

Trial Locations (20)

Unknown

Daegu Catholic University Medical Center, Daegu

Keimyung University Dongsan Medical Center, Daegu

Kyungpook National University Hospital, Daegu

Chungnam National University Hospital, Daejeon

Asan Medical Center, Gangneung

Chonnam National University Hospital, Gwangju

NHIC Ilsan Hospital, Ilsan

Chonbuk National University Hospital, Jeonju

Pusan Natioanal University Hospital, Pusan

Hallym University Sacred Heart Hospital,, Pyeongchon

Seoul National University Bundang Hospital, Seongnam

Korea University Anam Hospital, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul

St.Mary's Catholic Medical Center, Seoul

Yonsei University Medical Center, Seoul

Ajou University Hospital, Suwon

Ulsan University Hospital, Ulsan

Yonsei University Wonju Christian Hospital, Wŏnju

138-736

Asan Medical Center, Seoul

All Listed Sponsors
collaborator

CardioVascular Research Foundation, Korea

OTHER

lead

Seung-Jung Park

OTHER

NCT00590174 - Clopidogrel Use and Long-term Safety After Drug-Eluting Stents Implantation | Biotech Hunter | Biotech Hunter